Table of Contents 2
List of Tables 3
List of Figures 3
Spectranetics Corp Company Overview 4
Spectranetics Corp Company Snapshot 4
Spectranetics Corp Pipeline Products and Ongoing Clinical Trials Overview 4
Spectranetics Corp – Pipeline Analysis Overview 7
Spectranetics Corp - Key Facts 7
Spectranetics Corp - Major Products and Services 8
Spectranetics Corp Pipeline Products by Development Stage 10
Spectranetics Corp Ongoing Clinical Trials by Trial Status 12
Spectranetics Corp Pipeline Products Overview 14
CardioSculpt Valvuloplasty Scoring Balloon 14
CardioSculpt Valvuloplasty Scoring Balloon Product Overview 14
Drug Coated Balloon - In-stent Restenosis (ISR) 15
Drug Coated Balloon - In-stent Restenosis (ISR) Product Overview 15
Nexcimer 16
Nexcimer Product Overview 16
Next Gen Lead Management (LM) Tool 17
Next Gen Lead Management (LM) Tool Product Overview 17
Next-Gen Atherectomy Device 18
Next-Gen Atherectomy Device Product Overview 18
Next-gen Mechanical Tool 19
Next-gen Mechanical Tool Product Overview 19
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) 20
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) Product Overview 20
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) Clinical Trial 21
Stellarex Drug Coated Balloon - Above-The-Knee 22
Stellarex Drug Coated Balloon - Above-The-Knee Product Overview 22
Stellarex Drug Coated Balloon - Above-The-Knee Clinical Trial 23
Spectranetics Corp - Key Competitors 25
Spectranetics Corp - Key Employees 26
Spectranetics Corp - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Spectranetics Corp, Recent Developments 28
Sep 14, 2017: Efficacy of Philips’ Stellarex .035" low-dose drug-coated balloon demonstrated in clinical trial at two years 28
Sep 13, 2017: New Unpublished Vascular Clinical Trial Results on drug-coated balloons Presented at VIVA 17 28
Sep 13, 2017: New Unpublished Clinical Trial Results of Stellarex DCB Announced At VIVA 17 28
Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 29
Jul 26, 2017: Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon 29
Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 30
Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 30
Feb 23, 2017: Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million 31
Jan 24, 2017: ILLUMENATE Global 12-month Results Validate Stellarex’s Top-tier Performance in Complex Patient Populations 32
Jan 11, 2017: Spectranetics Names Scott Hutton as General Manager, Vascular Intervention 32
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Spectranetics Corp Pipeline Products and Ongoing Clinical Trials Overview 4
Spectranetics Corp Pipeline Products by Equipment Type 5
Spectranetics Corp Pipeline Products by Indication 6
Spectranetics Corp Ongoing Clinical Trials by Trial Status 6
Spectranetics Corp, Key Facts 7
Spectranetics Corp, Major Products and Services 8
Spectranetics Corp Number of Pipeline Products by Development Stage 10
Spectranetics Corp Pipeline Products Summary by Development Stage 11
Spectranetics Corp Ongoing Clinical Trials by Trial Status 12
Spectranetics Corp Ongoing Clinical Trials Summary 13
CardioSculpt Valvuloplasty Scoring Balloon - Product Status 14
CardioSculpt Valvuloplasty Scoring Balloon - Product Description 14
Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status 15
Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description 15
Nexcimer - Product Status 16
Nexcimer - Product Description 16
Next Gen Lead Management (LM) Tool - Product Status 17
Next Gen Lead Management (LM) Tool - Product Description 17
Next-Gen Atherectomy Device - Product Status 18
Next-Gen Atherectomy Device - Product Description 18
Next-gen Mechanical Tool - Product Status 19
Next-gen Mechanical Tool - Product Description 19
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Product Status 20
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Product Description 20
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Prospective, Randomized, Multi-center Study to Evaluate Treatment of Subjects with Occlusive Disease with a Novel Paclitaxel-coated Angioplasty Balloon in Below-The-Knee (BTK) Arteries - ILLUMENATE BTK 21
Stellarex Drug Coated Balloon - Above-The-Knee - Product Status 22
Stellarex Drug Coated Balloon - Above-The-Knee - Product Description 22
Stellarex Drug Coated Balloon - Above-The-Knee - Economic Evaluation Comparing Standard Balloon Angioplasty Versus Drug-eluted Balloon or Laser-excimer in Association with Drug-eluted Balloon in the Treatment of Femoropopliteal Artery In-stent Restenosis 23
Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Randomized, Single-blind, U.S. Multi-center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty Balloon: ILLUMENATE Pivotal 23
Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Single-arm, Global Multi-center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis: ILLUMENATE GLOBAL and ISR 23
Stellarex Drug Coated Balloon - Above-The-Knee - Stellarex Vascular E-Registry 24
Spectranetics Corp, Key Employees 26
Spectranetics Corp, Other Locations 27
Spectranetics Corp, Subsidiaries 27
Glossary 36

List of Figures
Spectranetics Corp Pipeline Products by Equipment Type 5
Spectranetics Corp Pipeline Products by Development Stage 10
Spectranetics Corp Ongoing Clinical Trials by Trial Status 12

Companies Mentioned
- Boston Scientific Corp
- Utah Medical Products Inc
- Abiomed Inc